The association of polypharmacy and high-risk drug classes with adverse health outcomes in the Scottish population with type 1 diabetes.
Andreas HohnStuart McGurnaghanThomas M CaparrottaStuart J McGurnaghanJoseph E O'ReillyLuke A K BlackbournRory J McCrimmonGraham P LeeseJohn A McKnightBrian KennonRobert S LindsayNaveed SattarSarah D WildPaul M McKeigueHelen Martina Colhounnull nullPublished in: Diabetologia (2021)
Polypharmacy is common among the Scottish population with type 1 diabetes and is strongly patterned by sociodemographic factors. The number of prescribed drugs and the prescription of particular high-risk drug classes are strong markers of an increased risk of adverse health outcomes, including acute complications of diabetes.